MedPath

Finding the Invasive Haemodynamic Threshold for Symptom Relief in Stable Angina

Recruiting
Conditions
Stable Angina
Interventions
Diagnostic Test: Rest-angina physiological assessment
Diagnostic Test: Exercise-angina physiological assessment
Registration Number
NCT05459051
Lead Sponsor
Imperial College London
Brief Summary

ORBITA-FIRE is a randomised, double-blinded, placebo controlled experimental study that will identify the fractional flow reserve (FFR) and non-hyperemic pressure ratio (NHPR) thresholds that correlate with symptoms of angina for 58 patients measured invasively under experimental conditions.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Eligibility for percutaneous coronary intervention (PCI) due to angina or angina-equivalent symptoms on exertion

  • Anatomical evidence of significant single-vessel coronary stenosis defined by either:

    • ≥70% stenosis on invasive coronary angiography (ICA)
    • Severe stenosis on CT coronary angiography (CTCA)
  • Physiological evidence of ischaemia with a positive test on at least one of the following:

    • Stress echocardiography
    • Cardiac magnetic resonance perfusion
    • Myocardial perfusion scintigraphy
    • Invasive metrics of coronary physiology
Exclusion Criteria
  • Age <18 years
  • Recent acute coronary syndrome
  • Previous coronary artery by-pass graft
  • Significant left main stem disease
  • Multivessel disease (defined as >50% angiographic stenosis in other vessels)
  • Chronic total occlusion in the target artery
  • Moderate to severe valvular disease
  • Moderate to severe left ventricular impairment
  • Chronotropic incompetence with a pacemaker
  • Contraindication to PCI or a drug-eluting stents
  • Contraindication to antiplatelet therapy
  • Contraindication to adenosine
  • Moderate to severe respiratory disease
  • Physical inability to exercise
  • Pregnant
  • Inability to consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with stable anginaExercise-angina physiological assessment* Symptomatic * Anatomically severe single-vessel coronary artery disease * Physiological evidence of myocardial ischaemia
Patients with stable anginaRest-angina physiological assessment* Symptomatic * Anatomically severe single-vessel coronary artery disease * Physiological evidence of myocardial ischaemia
Primary Outcome Measures
NameTimeMethod
The FFR and NHPR value at which the patient experiences angina in a rest stateIntra-procedural

Values 0.00-1.00 (Lower = More significant disease)

The FFR and NHPR value at which the patient experiences angina in an exercise stateIntra-procedural

Values 0.00-1.00 (Lower = More significant disease)

Secondary Outcome Measures
NameTimeMethod
The FFR difference between the rest and exercise statesIntra-procedural

Values 0.00-1.00 (Lower = More significant disease)

The NHPR difference between the rest and exercise statesIntra-procedural

Values 0.00-1.00 (Lower = More significant disease)

Angina severity score at the angina thresholdIntra-procedural

The patient scores the severity of the angina experienced during the procedure between 0-10 (Higher = More severe)

Angina similarity score at the angina thresholdIntra-procedural

The patient scores the similarity of the angina experienced during the procedure against the angina experienced before the procedure between 0-10 (Higher = Most similar)

Angina symptom type at the angina thresholdIntra-procedural

The patient will list all symptoms experienced at the angina threshold

Trial Locations

Locations (6)

Portsmouth Hospitals NHS Trust

🇬🇧

Portsmouth, United Kingdom

St George's University Hospitals NHS Foundation Trust

🇬🇧

London, United Kingdom

Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

🇬🇧

Bournemouth, United Kingdom

Mid and South Essex NHS Foundation Trust

🇬🇧

Basildon, United Kingdom

Imperial College NHS Trust

🇬🇧

London, United Kingdom

Royal Free Hospital NHS Foundation Trust

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath